Health Care Select Sector SPDR® ETF (XLV)
83.26
-0.02 -0.02%
NYSE Arca
May 22, 13:35
Delayed 2m
USD
XLV Key Stats
| Net Asset Value | Upgrade |
| Discount or Premium to NAV | Upgrade |
| Turnover Ratio | Upgrade |
View All XLV News
XLV News
-
WireHeadlineTime (ET)
-
MT Newswires05/22 09:22
-
SA Breaking News05/21 15:42
-
MT Newswires05/21 13:38
-
MT Newswires05/21 09:15
-
MT Newswires05/18 13:46
-
MT Newswires05/18 09:18
-
SA Breaking News05/18 08:21
-
MT Newswires05/17 13:36
-
MT Newswires05/17 09:20
-
MT Newswires05/16 13:33
XLV Performance
| Total Return (Price) | Total Return (NAV) | Cat. Total Return (NAV) | % Rank in Cat. (NAV) | |
|---|---|---|---|---|
| 1M | 1.45% | 1.49% | 2.02% | 88 |
| 3M | -0.65% | -0.59% | 1.54% | 83 |
| 6M | 2.81% | 2.86% | 9.70% | 89 |
| YTD | 1.08% | 1.23% | 6.46% | 85 |
| 1Y | 12.68% | 12.74% | 18.77% | 64 |
| 3Y | 5.08% | 5.10% | 4.03% | 38 |
| 5Y | 12.76% | 12.77% | 13.83% | 55 |
| 10Y | 12.16% | 12.16% | 13.29% | 68 |
XLV Asset Allocation
| Type | % Net | % Long | % Short |
|---|---|---|---|
| Cash | 0.16% | 0.16% | 0.00% |
| Stock | 99.84% | 99.84% | 0.00% |
| Bond | 0.00% | 0.00% | 0.00% |
| Convertible | 0.00% | 0.00% | 0.00% |
| Preferred | 0.00% | 0.00% | 0.00% |
| Other | 0.00% | 0.00% | 0.00% |
XLV Region Exposure
| Americas | 100.0% |
| North America | 100.0% |
| Latin America | 0.00% |
| Greater Europe | 0.00% |
| United Kingdom | 0.00% |
| Europe Developed | 0.00% |
| Europe Emerging | 0.00% |
| Africa/Middle East | 0.00% |
| Greater Asia | 0.00% |
| Japan | 0.00% |
| Australasia | 0.00% |
| Asia Developed | 0.00% |
| Asia Emerging | 0.00% |
| Market Classification | |
| % Developed Markets | 100.0% |
| % Emerging Markets | 0.00% |
XLV Stock Sector Exposure
| Basic Materials | 0.00% |
| Communication Services | 0.00% |
| Consumer Cyclical | 0.00% |
| Consumer Defensive | 0.00% |
| Energy | 0.00% |
| Financial Services | 0.00% |
| Healthcare | 99.41% |
| Industrials | 0.00% |
| Real Estate | 0.00% |
| Technology | 0.59% |
| Utilities | 0.00% |
XLV Stock Market Capitalization
| Giant | 55.52% |
| Large | 38.82% |
| Medium | 5.66% |
| Small | 0.00% |
| Micro | 0.00% |
XLV Stock Style Exposure
| Large Cap Value | 36.10% |
| Large Cap Blend | 23.61% |
| Large Cap Growth | 34.62% |
| Mid Cap Value | 1.22% |
| Mid Cap Blend | 2.06% |
| Mid Cap Growth | 2.38% |
| Small Cap Value | 0.00% |
| Small Cap Blend | 0.00% |
| Small Cap Growth | 0.00% |
View More Holdings
As of May 21, 2018
XLV Top 10 Holdings
| Symbol | Name | % Weight | Price | % Chg |
|---|---|---|---|---|
| JNJ | Johnson & Johnson | 10.26% | 122.89 | -0.67% |
| UNH | UnitedHealth Group Inc | 7.41% | 243.96 | -1.59% |
| PFE | Pfizer Inc | 6.59% | 35.90 | +0.28% |
| ABBV | AbbVie Inc | 5.23% | 106.92 | +0.65% |
| MRK | Merck & Co Inc | 4.88% | 58.80 | +0.39% |
| AMGN | Amgen Inc | 3.65% | 178.78 | +1.31% |
| MDT | Medtronic PLC | 3.57% | 85.06 | -0.30% |
| ABT | Abbott Laboratories | 3.34% | 61.49 | -1.00% |
| GILD | Gilead Sciences Inc | 2.74% | 68.24 | +0.90% |
| TMO | Thermo Fisher Scientific Inc | 2.69% | 218.22 | +0.69% |
Advertisement
XLV One Page Reports
- One Page Report Download
XLV Basic Info
| Style | |
|---|---|
| Equity Style | Large Cap/Blend |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Category Name | Health |
| Prospectus Objective | Specialty - Health |
| Fund Owner Firm Name | SPDR State Street Global Advisors |
| Benchmark Index | |
|---|---|
S&P Health Care Select Sector TR USD |
100.0% |
XLV Manager Info
| Name | Tenure |
|---|---|
| Dwayne Hancock | 1.16 yrs |
| Karl Schneider | 3.08 yrs |
| Michael Feehily | 7.08 yrs |
XLV Net Fund Flows
| 1M | -128.24M |
| 3M | -1.040B |
| 6M | -2.206B |
| YTD | -1.182B |
| 1Y | -2.226B |
| 3Y | 172.08M |
| 5Y | 1.535B |
| 10Y | 5.194B |
XLV Risk Info
| Beta (5Y) | 0.9081 |
| Max Drawdown (All) | 39.17% |
| Historical Sharpe (10Y) | 0.8948 |
| Historical Sortino (All) | 0.7039 |
| 30-Day Rolling Volatility | 13.71% |
| Daily Value at Risk (VaR) 1% (All) | 3.03% |
| Monthly Value at Risk (VaR) 1% (All) | 13.21% |
XLV Fundamentals
| Dividend Yield TTM (5-22-18) | 1.49% |
| SEC Yield (5-21-18) | 1.54% |
| Weighted Average PE Ratio | 26.22 |
| Weighted Average Price to Sales Ratio | 1.770 |
| Weighted Average Price to Book Ratio | 3.840 |
| Weighted Median ROE | 17.85% |
| Weighted Median ROA | 5.46% |
| Forecasted Dividend Yield | 1.78% |
| Forecasted PE Ratio | 15.39 |
| Forecasted Price to Sales Ratio | 1.654 |
| Forecasted Price to Book Ratio | 3.438 |
| Number of Holdings | 63 |
XLV Growth Estimates
| Forecasted 5 Yr Earnings Growth | 10.76% |
| Forecasted Book Value Growth | 6.82% |
| Forecasted Cash Flow Growth | 7.31% |
| Forecasted Earnings Growth | 0.79% |
| Forecasted Revenue Growth | 8.76% |
XLV Attributes
| Key Dates | |
|---|---|
| Inception Date | 12/16/1998 |
| Termination Date | |
| Last Annual Report Date | 9/30/2017 |
| Last Prospectus Date | 1/31/2018 |
| Attributes | |
| Exchange Traded Share | Yes |
| Exchange Traded Note | No |
| Enhanced Index Fund | No |
| Index Fund | Yes |
| Inverse Fund | No |
| Leveraged Fund | No |
| Fund of Funds | No |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |
| Has Dividend Investment Plan | Yes |
| General Availability | |
| Available for Insurance Product | No |
| Available for Retirement Plan | No |
| Available for RRSP | No |
XLV Excel Add-In Codes
- Name: =YCI("XLV","name")
- Broad Asset Class: =YCI("XLV", "broad_asset_class")
- Broad Category: =YCI("XLV", "broad_category_group")
- Prospectus Objective: =YCI("XLV", "prospectus_objective")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Advertisement
